Navigation Links
DURECT Corporation Announces Fourth Quarter and Year End 2010 Financial Results
Date:3/2/2011

ns for TRANSDUR-Sufentanil.  We are in discussions with potential partners regarding licensing development and commercialization rights to this program to which we hold worldwide rights.TRANSDUR-Sufentanil is our proprietary transdermal patch intended to deliver sufentanil to chronic pain sufferers for a period of up to seven days from a single application.


  • ORADUR-ADHD Program.  In July 2010, we commenced a Phase I clinical trial in this program evaluating multiple formulations.   ORADUR-ADHD applies our proprietary ORADUR technology to leading active pharmaceutical ingredients for the treatment of attention deficit disorder (ADHD).  Under an agreement with Orient Pharma, we are collaborating to perform a clinical development program through a Phase II study intended to produce a data package anticipated to support later stage development of one ADHD drug candidate and subsequent licensing by DURECT. We are responsible for formulation and study design of the pre-defined clinical program, which Orient Pharma will fund and execute.


  • Feasibility Projects and Other Activities.  During 2010, we conducted several feasibility projects as a means of demonstrating that our technologies can achieve the drug delivery objectives set forth by our collaborators and are worthy of further development.  During 2011, we anticipate establishing and commencing additional feasibility projects with biotechnology and pharmaceutical company collaborators utilizing our drug delivery technologies.  In February 2011, we announced that our collaborator, CreoSalus, had launched commercial sales of SucroMate™ Equine, an FDA approved product which is an injectable animal health drug utilizing DURECT's SABER technology to deliver the peptide deslorelin. DURECT will receive a royalty on net sales of this product and will supply one of the key excipients in the product. Althoug
    '/>"/>


  • SOURCE DURECT Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. DURECTs Collaboration With Alpharma Clears HSR Review and Is Effective
    2. DURECT Corporation Announces Third Quarter 2008 Financial Results
    3. DURECT Corporation Invites You to Join its Third Quarter 2010 Earnings Conference Call
    4. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
    5. Pharmos Corporation Reports 2008 Second Quarter Results
    6. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
    7. Genaera Corporation Announces Second Quarter Financial Results
    8. MannKind Corporation Reports Second Quarter Financial Results
    9. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
    10. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
    11. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/19/2014)... 20, 2014 United States Non-Vascular ... GlobalDatas new report, "United States Non-Vascular Stents Market ... the United States Non-Vascular Stents market. The report ... (in units) and average prices (in US dollars) ... Stents and Metal Biliary Stents (Metal Non-Covered Biliary ...
    (Date:7/18/2014)... , July 18, 2014  Neogen Corporation (Nasdaq: ... , Neogen,s chief operating officer and president, has resigned, ... work as a consultant going forward on special projects. ... has been in this position since September 2013. On ... James Herbert , who has been Neogen,s chief ...
    (Date:7/18/2014)... world is mostly neutral. That is, most of ... The number of electrons in the outer parts of ... of atoms. As one or more electrons are ... a much stronger positive pull from the nucleus. ... size, ensures that those electrons are less vulnerable to ...
    (Date:7/18/2014)... 2014  Neurotrope, Inc. (OTCQB: NTRP) today announced that ... Co-Chairmen Charles S. Ramat and Paul ... basis, effective immediately. Messrs. Ramat and Freiman replace Dr. ... Executive Officer of Neurotrope Bioscience, Inc., (a wholly-owned subsidiary ... agreement with Neurotrope Bioscience Inc. terminated as of July ...
    Breaking Biology Technology:United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4Highly charged ions 2Highly charged ions 3Highly charged ions 4Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 2Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 3Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 4
    ... , , , ... (Nasdaq: ARAY ), a global leader in the ... the treatment planning capabilities of the CyberKnife(R) Robotic Radiosurgery System ... Oncology (ESTRO) Conference on Physics and Radiation Technology for Clinical ...
    ... , , , ... leading provider of cGMP contract manufacturing of biologics and other key services, ... appointments of Truc Le as chief operating officer and Christopher Eso as ... in expanding its customer base and growing its manufacturing revenues, as well ...
    ... LEUVEN, Belgium, August 27 ThromboGenics NV,(Euronext Brussels: THR), ... treatments for eye disease, vascular disease,and cancer, is today issuing ... month period ending 30 June, 2009. , ... activities which,are key to its aim of becoming a profitable, ...
    Cached Biology Technology:Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference 2Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference 3Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference 4Avid Bioservices Expands Executive Team as it Prepares for Continued Growth 2Avid Bioservices Expands Executive Team as it Prepares for Continued Growth 3Avid Bioservices Expands Executive Team as it Prepares for Continued Growth 4Avid Bioservices Expands Executive Team as it Prepares for Continued Growth 5ThromboGenics NV Announces Business Update and Half Year Results 2009 2ThromboGenics NV Announces Business Update and Half Year Results 2009 3ThromboGenics NV Announces Business Update and Half Year Results 2009 4ThromboGenics NV Announces Business Update and Half Year Results 2009 5ThromboGenics NV Announces Business Update and Half Year Results 2009 6ThromboGenics NV Announces Business Update and Half Year Results 2009 7ThromboGenics NV Announces Business Update and Half Year Results 2009 8ThromboGenics NV Announces Business Update and Half Year Results 2009 9ThromboGenics NV Announces Business Update and Half Year Results 2009 10ThromboGenics NV Announces Business Update and Half Year Results 2009 11ThromboGenics NV Announces Business Update and Half Year Results 2009 12ThromboGenics NV Announces Business Update and Half Year Results 2009 13ThromboGenics NV Announces Business Update and Half Year Results 2009 14ThromboGenics NV Announces Business Update and Half Year Results 2009 15
    (Date:7/21/2014)... Millar , a professor of entomology and ... at the University of California, Riverside, has been ... International Society of Chemical Ecology ( ISCE ). , ... is the society,s highest honor. It is awarded ... chemical ecology, the study of chemicals that mediate interactions ...
    (Date:7/21/2014)... to conserve water and save on your utility bill? ... published in the current issue of the journal ... The Most Effective Actions U.S. Households Can Take to ... use substantially by simple actions such as installing more ... While the suggestions may be familiar, the researchers are ...
    (Date:7/21/2014)... and cheating in science are among the topics ... mycology experts in Montreal at the three International ... 27 to August 1, 2014. Some 2,000 participants ... the 14th International Congress of Bacteriology and Applied ... Eukaryotic Microbiology, and the 16th International Congress of ...
    Breaking Biology News(10 mins):UC Riverside entomologist receives international honor for chemical ecology contributions 2Researchers provide guide to household water conservation 2Researchers provide guide to household water conservation 3Montreal hosts International Union of Microbiology Societies congresses 2
    ... grown in popularity, so have complaints of adverse side ... new study, done by chemistry students at Northern Arizona ... of tattoo inks to better understand their potential health ... national meeting of the American Chemical Society, the world's ...
    ... medical conference here heard that an Australian developed ... common cold virus to control cancer cell growth ... The research was presented to the third International ... 11 March by Newcastle University associate professor, Darren ...
    ... In a 12-hour, dual-stage surgery known to be performed ... at the University of Alabama at Birmingham on Tuesday ... surgically removing his pancreas to eliminate constant, severe pain ... of Panama City, Fla., remained anesthetized in the operating ...
    Cached Biology News:Chemicals in tattoo inks need closer scrutiny 2Chemicals in tattoo inks need closer scrutiny 3Anti cancer virotherapy well tolerated in first human administration, research finds 2Rare surgery performed to remove pancreas, prevent diabetes 2
    The imaging screen-K (Kodak), is a 35 x 43 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
    The optional fixed lens, 105 mm, is for use with the VersaDoc imaging systems for imaging small samples at high resolution....
    The filter 695RDF55 Reflect 635 for the Molecular Imager FX is a band pass filter for Cy5 and Alexa Fluor 635 dyes....
    The HQ505, 20 OptiGreen filter for the Molecular Imager FX is a band pass filter used for detection of Cy2 and FITC with 532 nm excitation....
    Biology Products: